...
首页> 外文期刊>Cell death & disease. >The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury
【24h】

The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury

机译:mTOR信号调节急性肾损伤中髓样抑制细胞的分化和免疫抑制功能

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The mammalian target of rapamycin (mTOR) signal controls innate and adaptive immune response in multiple immunoregulatory contexts. Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of myeloid cells of potent immunosuppressive capacity. In this study, we aimed to investigate the role of MDSCs in the protection of acute kidney injury (AKI) and the regulation of mTOR signal on MDSC’s protective role in this context. In mice AKI model, rapamycin administration was associated with improved renal function, restored histological damage and decreased CD4+ and CD8+ T-cell infiltration in kidney tissue. MDSCs, especially CD11b+Ly6G+Ly6Clow G-MDSCs were recruited to the injured kidney following the interaction of CXCL1, CXCL2 and their receptor CXCR2 after inhibiting mTOR signal with rapamycin treatment. The adoptive transfer of rapamycin-treated MDSCs into the mice with AKI significantly improved the renal function, ameliorated histologic damages and limited the infiltration of T cells in kidney tissue. In addition, the expression of pro-inflammatory cytokines IL-1 β and IFN- γ mRNA was downregulated while the expression of TGF- β 1 and Foxp3 mRNA was upregulated in kidney tissue after transferring rapamycin-treated MDSCs. Adoptive transfer of rapamycin-treated MDSCs also downregulated the serum levels of IL-1 β , IL-6 and IFN- γ and upregulated the serum levels of TGF- β 1 compared with the IR group and PBS-treated MDSC group. In in vitro study, inhibiting mTOR signal regulated the induction of MDSC towards the CD11b+Ly6G+Ly6Clow G-MDSC subset. The ability to suppress T-cell proliferation of both bone marrow–derived CD11b+Ly6G+Ly6Clow G-MDSCs and CD11b+Ly6G-Ly6Chigh M-MDSCs was enhanced by mTOR signal inhibition via upregulating the expression of Arginase-1 and iNOS. Accordingly, both G-MDSCs and M-MDSCs presented downregulated runx1 gene expression after rapamycin treatment. Taken together, our results demonstrated that MDSCs ameliorated AKI and the protective effect was enhanced by mTOR signal inhibition via promoting MDSCs recruitment, regulating the induction of MDSCs and strengthening their immunosuppressive activity.
机译:雷帕霉素(mTOR)信号的哺乳动物靶标在多种免疫调节环境中控制先天性和适应性免疫反应。髓样来源的抑制细胞(MDSC)是具有有效免疫抑制能力的异种髓样细胞群体。在这项研究中,我们旨在研究MDSC在保护急性肾损伤(AKI)中的作用以及在这种情况下mTOR信号对MDSC的保护作用的调控。在小鼠AKI模型中,雷帕霉素的给药可改善肾脏功能,恢复组织学损伤,并减少肾脏组织中CD4 + 和CD8 + T细胞的浸润。在CXCL1,CXCL2及其受体CXCR2相互作用后,MDSCs,尤其是CD11b + Ly6G + Ly6C low G-MDSCs被募集到受伤的肾脏。雷帕霉素治疗抑制mTOR信号后。雷帕霉素处理过的MDSC过继转移至AKI小鼠体内可显着改善肾脏功能,减轻组织学损伤,并限制T细胞在肾脏组织中的浸润。此外,在转移雷帕霉素处理的MDSC后,肾脏组织中促炎细胞因子IL-1β和IFN-γmRNA的表达下调,而TGF-β1和Foxp3 mRNA的表达上调。与IR组和PBS处理的MDSC组相比,雷帕霉素处理的MDSC的过继转移还下调了IL-1β,IL-6和IFN-γ的血清水平,并上调了TGF-β1的血清水平。在体外研究中,抑制mTOR信号可调节MDSC对CD11b + Ly6G + Ly6C 低 G-MDSC亚型的诱导。抑制源自骨髓的CD11b + Ly6G + Ly6C low G-MDSCs和CD11b +的T细胞增殖的能力 Ly6G - Ly6C 高 M-MDSCs通过上调Arginase-1和iNOS的表达而受到mTOR信号抑制。因此,雷帕霉素治疗后,G-MDSCs和M-MDSCs都下调了runx1基因表达。两者合计,我们的结果表明,MDSCs改善了AKI,并且通过促进MDSCs募集,调节MDSCs的诱导和增强其免疫抑制活性而通过mTOR信号抑制增强了保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号